A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients
medicalxpress - A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC), according to a study presented at the American A…
AI Summary: Researchers developed a deep‑learning pathomics platform that analyzes routine histology to predict which lung cancer patients are likely to respond to immunotherapy. By extracting subtle morphological patterns invisible to the human eye, the tool promises to refine treatment selection and spare nonresponders unnecessary toxicity—assuming clinicians trust an algorithm more than their gut.
- AI pathomics flags immunotherapy responders in lung cancer (4)
- Challenges deploying AI in lung cancer diagnosis and care (3)
- Evolving lung cancer immunotherapy trials and biomarker debates (4)
- All Other Stories
AI pathomics flags immunotherapy responders in lung cancer
Challenges deploying AI in lung cancer diagnosis and care
Evolving lung cancer immunotherapy trials and biomarker debates
All Other Stories
Related Stories
Mobile app symptom monitoring maintains quality of life in advanced cancer / 4 wks
AI model generalizes to predict immunotherapy response across cancers / 6 days
AI face photos may predict cancer survival years earlier / 2 months
Journal retracts study claiming morning immunotherapy benefit / 14 days
Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 3 months
Small study reports 100% one‑year survival after lung transplant / 19 hrs
High‑dose targeted radiation shows promise for huge bile duct tumors / 3 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Medical Devices, Behavioral Health, Hospital Operations, Genetics and look for the RSS link.
StackHealth Time Machine